Therapeutic Agent for Keratoconjunctival Disorder
OwnerKeiichi Shibagaki, Shin-ichiro Hirai +1inventors
InventorsKeiichi Shibagaki, Shin-ichiro Hirai, Masatsugu Nakamura
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to discover a new use of eprosartan or a salt thereof. Eprosartan or a salt thereof exhibits an excellent improving effect in a corneal disorder model, and therefore is useful as a therapeutic agent for a keratoconjunctival disorder such as dry eyes, corneal ulcer, keratitis, conjunctivitis, superficial punctate keratopathy, corneal epithelial defects, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis and filamentary keratitis.
Claims12
A therapeutic agent for a keratoconjunctival disorder, comprising eprosartan or a salt thereof as an active ingredient.
A method for treating a keratoconjunctival disorder comprising administering to a patient a therapeutically effective amount of eprosartan or a salt thereof.
Use of eprosartan or a salt thereof for manufacturing a therapeutic agent for a keratoconjunctival disorder.
Dependencies are inferred from the claim text.